Oxarbazole
- Level
- Commodity
- Parent
- 51161500
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51161543This classification denotes an anti-asthmatic agent with the molecular formula C21H19NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A34YCH7N8A, chemically known as 9-benzoyl-1,2,3,4-tetrahydro-6-methoxycarbazole-3-carboxylic acid but generally known as oxarbazole, which bears US NIH Compound Identifier 37184. European Medicines Agency schedules Oxarbazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09503MIG. The term OXARBAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). OXARBAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule oxarbazole under HS 29339990 and SITC 51577. As of Q4 2014, OXARBAZOLE remains the US FDA Preferred Term for this commodity. Oxarbazole bears US NLM identifiers UMLS ID C0069741 and NCI Concept Code C81436. SMILES: OC(=O)C1CC2C(N(C3C2CC(OC)CC3)C(=O)C2CCCCC2)CC1.
Same parent
Under 51161500 · 56Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.